MRSA Notes

Solvay, an international chemical and pharmaceutical group located in Brussels, has developed a biocidal product, Perestane, that is an effective disinfectant against MRSA and C. difficile.

Perestane®, which Solvay is marketing presently in the European Union, is a disinfectant based on peracid chemistry with a range of potential applications in the public and domestic health domains (for instance: disinfection of medical instruments, superior quality household products, etc.). This very low odor biocide possesses all the qualities of some other peracid compounds – such as high disinfectant efficacy even with short contact times and a low impact on the environment – without the drawbacks of a strong pungent smell. In addition, it can demonstrate much lower corrosion rates against some of the materials frequently encountered in hospitals when compared to other oxidizing biocides.

“With Perestane®, Solvay has developed an innovative highly efficient, user- and environment-friendly disinfectant that can be implemented in various demanding applications,” said Eric Mignonat, Solvay’s General Manager for Peroxide business. “Through our chemical research and know-how, we have also succeeded in providing a workable solution for an emerging, life-threatening problem. We can help to make hospitals safer places to be,” added Eric Mignonat. Source

Perestane is currently only being marketed in the European Union.

HA MRSA, Infection Prevention, MRSA, Research and Development

Share This